Oneness Biotech Co., Ltd.

This study tests an experimental drug called FB825 in 90 adults with moderate-to-severe atopic dermatitis (eczema). Participants receive either FB825 or a placebo via injection under the skin. The goal is to see if the drug reduces eczema severity and itching, and to check its sa…

This study tests a new drug called FB825 for adults with moderate-to-severe allergic asthma. About 100 participants will receive either FB825 or a placebo to see if it reduces asthma attacks and improves breathing. The goal is to better control the disease, not cure it.

This study tests an experimental drug called FB704A in adults with severe asthma. The goal is to see if it is safe and can help control asthma symptoms. About 20 participants will receive either the drug or a placebo over 8 weeks, with follow-up for 12 more weeks.

This early-stage study is testing a new drug, SNS851, in 52 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by injection. The main goal is to check for side effects, not to treat any disease.